Ruxolitinib for Cancer Cachexia
Ruxolitinib for Cancer Cachexia
Active, not recruiting · NCT04906746 · Registry updated 2026-07-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ruxolitinib for Cancer Cachexia | Anorexia, Atrophy, Body Weight, Body Weight Changes, Cachexia, Neoplasms by Site, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Thinness, Thoracic Neoplasms, Weight Loss, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, muscular atrophy, neoplasm, nervous system disorder, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Early phase 1 | 2026-07-07 | NCT04906746 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Incyte Corporation | 153 |
| Tu Dan | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UT Southwestern Medical Center | Dallas | United States | 210 |